Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Sao Paulo, Brazil
Countries of investment
  • Belgium
  • UK
  • Sweden
  • Spain
Investment stages
  • Seed
  • Series A
  • Series B
Industries
    About
    Global venture capital firm investing in diagnostics start-ups and digital solutions to revolutionize healthcare.
    Min check size
    $500K
    Max check size
    $5M
    Fund size
    NPS

    Investment Thesis

    We strive to support our portfolio companies over the longterm, leveraging our global network and providing strategic support with scientific, technical, and market knowledge to maximize success. We Venture Capital focuses on investing in innovative health and biotechnology companies, including sectors such as therapeutic drug monitoring, genomics tertiary analysis, dried blood spot, and sepsis diagnosis. The firm believes in technological advancement as a means to improve patient outcomes and revolutionize healthcare.
    Lead investor
    Co Invest
    Number of exits
    Preferred contact method

    Manager's Experience

    With a robust background in venture capital, the fund manager has executed over 50 investments primarily in the technology and healthcare sectors. Active in North America and Europe, they emphasize early to growth-stage opportunities while employing a data-driven approach to identify high-potential startups. Notable exits include several successful IPOs and acquisitions, reflecting a strategic focus on scalable business models. Their operator-first mindset positions them uniquely to support portfolio companies through strategic guidance and operational expertise.
    Fund number
    Vintage Year
    Net Internal Rate of Return
    Investment Multiple
    Capital Allocation
    Management Fee
    Carried Interest
    AUM
    Follow-on Investments
    Graduation Rate
    Write-Off Ratio
    Last profile update timestamp